Literature DB >> 28932893

Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor.

Justin S Alpert1, Patrick Boland2,3, Meera Hameed4, David M Panicek5,3.   

Abstract

Recurrence of a soft tissue sarcoma typically manifests as a round or oval mass at imaging, and recurrent high-grade soft tissue sarcomas generally enlarge relatively rapidly. We present a case of high-grade undifferentiated pleomorphic sarcoma in the calf of a 48-year-old male that recurred as a thin, curvilinear "tail" of enhancing tissue at magnetic resonance imaging (MRI), with extremely indolent growth over a 7-year period. The unusual imaging finding of a slowly enlarging "tail" should not be dismissed as postoperative changes, even for a high-grade soft tissue sarcoma.

Entities:  

Keywords:  Magnetic resonance imaging; Malignant fibrous histiocytoma; Postoperative change; Soft tissue sarcoma; Undifferentiated pleomorphic sarcoma

Mesh:

Year:  2017        PMID: 28932893      PMCID: PMC6625664          DOI: 10.1007/s00256-017-2778-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  10 in total

1.  Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease.

Authors:  Brendan Waters; David M Panicek; Robert A Lefkowitz; Cristina R Antonescu; John H Healey; Edward A Athanasian; Murray F Brennan
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

2.  Current treatment of soft tissue sarcoma.

Authors:  Shawn Steen; Gerald Stephenson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

3.  Malignant fibrous histiocytoma: an institutional review.

Authors:  J F Gibbs; P P Huang; R J Lee; B McGrath; J Brooks; B McKinley; D Driscoll; W G Kraybill
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

4.  Gadolinium Contrast Enhancement Improves Confidence in Diagnosing Recurrent Soft Tissue Sarcoma by MRI.

Authors:  Shinn-Huey S Chou; Daniel S Hippe; Amie Y Lee; Kurt Scherer; Jack A Porrino; Darin J Davidson; Felix S Chew; Alice S Ha
Journal:  Acad Radiol       Date:  2017-01-20       Impact factor: 3.173

5.  Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma.

Authors:  Karl E Haglund; Chandrajit P Raut; Alessandra F Nascimento; Qian Wang; Suzanne George; Elizabeth H Baldini
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-15       Impact factor: 7.038

6.  Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.

Authors:  Robert A Lefkowitz; Jonathan Landa; Sinchun Hwang; Emily C Zabor; Chaya S Moskowitz; Narasimhan P Agaram; David M Panicek
Journal:  Skeletal Radiol       Date:  2013-01-15       Impact factor: 2.199

7.  Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.

Authors:  Hsuan-Ying Huang; Priti Lal; Jing Qin; Murray F Brennan; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2004-05       Impact factor: 3.466

8.  MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value.

Authors:  Hye Jin Yoo; Sung Hwan Hong; Yusuhn Kang; Ja-Young Choi; Kyung Chul Moon; Han-Soo Kim; Ilkyu Han; Minkyong Yi; Heung Sik Kang
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

Review 9.  WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.

Authors:  Vickie Y Jo; Christopher D M Fletcher
Journal:  Pathology       Date:  2014-02       Impact factor: 5.306

10.  Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma.

Authors:  A Daigeler; I Zmarsly; T Hirsch; O Goertz; H-U Steinau; M Lehnhardt; K Harati
Journal:  Br J Cancer       Date:  2014-01-30       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.